tiprankstipranks
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
Holding SABS?
Track your performance easily

SAB Biotherapeutics (SABS) Income Statement

85 Followers

SAB Biotherapeutics Income Statement

Last quarter (Q3 2024), SAB Biotherapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, SAB Biotherapeutics's net income was $-10.35M. See SAB Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.21M$ 2.24M$ 23.90M$ 60.88M$ 55.24M$ 3.44M
Cost of Revenue
------
Gross Profit
$ 2.48M$ 2.24M$ 23.90M$ 60.88M$ 55.24M-
Operating Expense
$ 40.70M$ 38.08M$ 52.82M$ 74.27M$ 34.68M$ 12.12M
Operating Income
$ -38.22M$ -38.08M$ -28.92M$ -13.39M$ 20.56M$ -8.67M
Net Non Operating Interest Income Expense
$ 924.80K$ 269.68K$ -230.51K$ -271.34K$ -443.02K$ -315.34K
Other Income Expense
$ -9.56M$ -4.39M$ -10.43M$ 3.48M$ -4.00K$ 2.59K
Pretax Income
$ -27.81M$ -42.19M$ -18.72M$ -17.14M$ 20.12M$ -8.99M
Tax Provision
-$ -452.45K$ 25.63K$ -108.76K$ -1.30M-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -27.81M$ -42.19M$ -18.74M$ -17.14M$ 20.12M$ -8.99M
Basic EPS
$ -3.45$ -7.64$ -0.43$ -6.30$ 0.79$ -0.21
Diluted EPS
$ -3.45$ -7.64$ -0.43$ -6.30$ 0.74$ -0.21
Basic Average Shares
$ 33.00M$ 5.52M$ 43.52M$ 2.73M$ 25.39M$ 43.47M
Diluted Average Shares
$ 33.00M$ 5.52M$ 43.52M$ 2.73M$ 27.01M$ 43.47M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 40.70M$ 38.08M$ 52.82M$ 74.27M$ 34.68M$ 12.12M
Net Income From Continuing And Discontinued Operation
$ -27.81M$ -42.19M$ -18.74M$ -17.14M$ 20.12M$ -8.99M
Normalized Income
$ -17.51M-$ -14.80M--$ -8.99M
Interest Expense
-----$ 428.48K
EBIT
$ -27.51M$ -42.33M$ -18.71M$ -17.14M$ 20.59M$ -8.56M
EBITDA
$ -22.51M$ -38.59M$ -15.42M$ -15.49M$ 21.14M$ -8.23M
Currency in USD

SAB Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis